"Investors are actually quite happy that Nova will not be purchasing MSA. So shares rose for Nova Nordisk this morning after it withdrew over the weekend its $10 billion offer for Midsera the obesity startup. So that means that FISA will now be buying the company. Investors are not seeing this as a setback for Nova Nordisk but more Nova walking away from something that might have been quite difficult to pull off maybe."
Nova Nordisk's decision to withdraw its $10 billion bid for an obesity startup is being welcomed by investors, as it avoids potential regulatory and pricing issues. The market reacted positively with a rise in shares, signaling that the move is viewed as a strategic retreat rather than a failure.
Diageo Gains, Novo Rises, Siemens Energy Up | Stock Movers
Stock Movers
November 10, 2025
Company Opinion